• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVyera Pharmaceuticals

Vyera Pharmaceuticals

Page 3 of 4
MSMB Capital Management CIO Martin Shkreli
FinanceTuring CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring Says it Will Lower Daraprim Price by the End of the Year
By Laura LorenzettiNovember 4, 2015
Why the drug price scandal won’t be enough to keep down prices
RetailWhy the drug price scandal won’t be enough to keep down prices
By Laura LorenzettiOctober 26, 2015
Imprimis Turing Drug
HealthThis company is offering a $1 alternative to Turing’s $750 drug
By Laura LorenzettiOctober 23, 2015
MSMB Capital Management CIO Martin Shkreli
HealthThis super-expensive drug is getting a $1 rival
By Benjamin SnyderOctober 23, 2015
Democratic Candidates Attend New Hampshire Democratic Party Convention
LeadershipBernie Sanders rejects drug price-raising CEO’s donation: ‘We don’t want his stinkin’ money’
By Michal AddadyOctober 16, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
HealthValeant under federal investigation for how it prices drugs
By Laura LorenzettiOctober 15, 2015
117046657
LeadershipDo today’s philanthropists hurt more than they help?
By Linsey McGoeyOctober 6, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
HealthThe drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthBiotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
MSMB Capital Management CIO Martin Shkreli
HealthRecord label cuts ties with besieged pharma CEO Martin Shkreli
By Daniel RobertsSeptember 25, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
LeadershipDonald Trump on drug price-raising CEO: ‘Spoiled brat’
By Laura LorenzettiSeptember 24, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring backs down on Daraprim drug pricing
By TIMESeptember 23, 2015
157934085
HealthDoctors respond to Turing drug price hike: ‘It’s scare mongering’
By Laura LorenzettiSeptember 22, 2015
HIllary Rodham Clinton
HealthHillary Clinton releases health plan that aims to combat skyrocketing drug costs
By Laura LorenzettiSeptember 22, 2015
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
AI
Thousands of CEOs admit AI had no impact on employment or productivity—and it has economists resurrecting a paradox from 40 years agoplaceholder alt text
By Sasha RogelbergApril 19, 2026
Energy
Markets shudder as Strait of Hormuz starts resembling a combat zone. 'We're prepared to subject you to disabling fire'placeholder alt text
By Jason MaApril 19, 2026
Economy
The explosion of U.S. debt is wiping out the 'safety premium' of Treasury bonds, and time is running out for an orderly fiscal solution, IMF warnsplaceholder alt text
By Jason MaApril 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.